NAV
9.99(-0.60%)Fund Size (CR)
₹107.37Expense Ratio
0.66Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹1,000Minimum Withdrawal
₹1,000Exit Load
0.5%Return Since Launch
-0.10%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Anandha Padmanabhan Anjen
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 8 September 2025 | 10090.91 | 0.91% | - | 1.29% | 690/916 |
| 1 Month | 14 August 2025 | 9910.71 | -0.89% | - | 2.88% | 837/908 |
| 3 Month | 13 June 2025 | 10070.56 | 0.71% | - | 3.27% | 509/876 |
| 6 Month | 13 March 2025 | 11187.01 | 11.87% | - | 17.29% | 672/856 |
| 1 Year | - | - | - | - | -1.28% | -/- |
| 3 Year | - | - | 0% | - | 18.75% | -/- |
| 5 Year | - | - | 0% | - | 22.71% | -/- |
| Since Inception | 6 December 2024 | 9990.00 | -0.10% | -0.10% | 13.80% | 827/916 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 1 January 2025 | 90,000 | 93281.51 | 3.65% | 3.65% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
5.25%
Standard Deviation
1.11%
Beta
-0.44%
Sharpe Ratio
-0.03%
Treynor's Ratio
-6.17%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 12.28% | 82708 | 13.19 | Equity | Pharmaceuticals |
| Divi's Lab. | 8.84% | 15479 | 9.49 | Equity | Pharmaceuticals |
| Max Healthcare | 7.48% | 69591 | 8.03 | Equity | Healthcare |
| Dr Reddy's Labs | 6.44% | 54891 | 6.92 | Equity | Pharmaceuticals |
| Aster DM Health. | 5.70% | 101849 | 6.12 | Equity | Healthcare |
| Mankind Pharma | 5.17% | 22445 | 5.55 | Equity | Pharmaceuticals |
| Torrent Pharma. | 5.11% | 15400 | 5.48 | Equity | Pharmaceuticals |
| Krishna Institu. | 3.95% | 58577 | 4.24 | Equity | Healthcare |
| Abbott India | 3.48% | 1188 | 3.74 | Equity | Pharmaceuticals |
| Global Health | 3.39% | 26471 | 3.64 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| PGIM India Healthcare Fund - Direct (G) | 107.37 | -0.89% | 0.71% | 11.87% | - | - | |
| Nippon India Taiwan Equity Fund - Direct (G) | 389.09 | 9.08% | 28.31% | 50.57% | 47.77% | 33.03% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 389.09 | 9.08% | 28.31% | 50.57% | 47.77% | 33.03% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 249.75 | 2.95% | 11.02% | 19.06% | 28.03% | 17.07% | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 249.75 | 2.95% | 11.02% | 19.06% | 28.03% | 17.07% | |
| Nippon India Japan Equity Fund - Direct (G) | 283.56 | 3.22% | 10.49% | 15.86% | 19.19% | 18.55% |
List of Schemes under PGIM India Mutual Fund
News
PGIM India Mutual Fund announces Monthly Income Distribution cum Capital Withdrawal (IDCW) under its schemes
PGIM India Mutual Fund has announced 17 September 2025 as the record date for declaration of IDCW under the following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:PGIM India Arbitrage Fund:
Regular Plan ' Monthly IDCW Option: 0.0452
Direct Plan ' Monthly IDCW Option: 0.0458
PGIM India Aggressive Hybrid Equity Fund:
Regular Plan ' Monthly IDCW Option: 0.1649
Direct Plan ' Monthly IDCW Option: 0.1842
PGIM India Equity Savings Fund:
Regular Plan ' Monthly IDCW Option: 0.0654
Direct Plan ' Monthly IDCW Option: 0.0718
Powered by Capital Market - Live News
PGIM India Mutual Fund announces change in Key Personnel
PGIM India Mutual Fund has announced the Mr. Abhishek Tiwari has been appointed as a Chief Executive Officer and Key Personnel of PGIM Asset Management Private Limited With effect from 01 September 2025Details of Mr. Abhishek Tiwari
Age: 27 years
Designation: Chief Executive Officer
Qualification: PGDM, Nirma University
Powered by Capital Market - Live News
PGIM India Mutual Fund announces change in Key Personnel
PGIM India Mutual Fund has announced that Mr. Aditya Kulkarni has been appointed as a Dealer ' Equities on the Board of the Trustee Company with effect from July 01, 2025.Details of Mr. Aditya Kulkarni
Age: 25
Designation: Dealer ' Equities
Qualification : MBA in Finance Management & BE in Electrical Engineering
Experience : 2
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
19 November 2024
Total AUM (Cr)
₹107.37
PGIM India Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, PGIM India Mutual Fund. Launched in 19 November 2024, this fund is managed by Anandha Padmanabhan Anjen. With assets under management (AUM) worth ₹107.37 (Cr), as of 15 September 2025, PGIM India Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of -0.10% since its launch.
The current NAV of PGIM India Healthcare Fund - Direct (G) is ₹9.99, as on 15 September 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in PGIM India Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹1,000 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.26% in Equity, 1.68% in Debt and 0.06% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.52% in Pharmaceuticals & Biotech, 29.37% in Healthcare Services, 2.85% in Financial Technology (Fin, 2.58% in Chemicals & Petrochemical, 2.40% in Insurance